What can you mix with tranexamic acid?
- Use tranexamic acid at a different time of day from AHA/BHA peel, one in the morning and the other at night.
- Tranexamic acid with hydroquinone needs care: start slowly or alternate days.
- Tranexamic acid sits happily next to retinol, tretinoin, adapalene, vitamin C, niacinamide, glycolic acid, lactic acid, salicylic acid, benzoyl peroxide, azelaic acid, hyaluronic acid, ceramides, peptides, copper peptides, bakuchiol, vitamin E, ferulic acid, sunscreen, mandelic acid, alpha arbutin, kojic acid, snail mucin, centella asiatica and squalane.
What it does
Tranexamic acid is a lysine analogue best known as a medicine that reduces bleeding. In skin it blocks plasminogen from binding to keratinocytes, which cuts down a chain of signals (including prostaglandins) that prompt melanocytes to make more pigment. That is why it is used for melasma, which UV and hormones keep re-triggering.[1]
Strengths
- A 2024 meta-analysis concluded tranexamic acid lowers melasma severity scores.[1]
- A randomized trial found 3% tranexamic acid cream comparable to 4% hydroquinone for melasma, with possible advantages in side effects.[2]
- A 2024 review found microneedling combined with topical tranexamic acid improved melasma outcomes.[3]
Who it suits
People with melasma or stubborn sun spots, especially those who cannot use hydroquinone, and sensitive skin that dislikes acids.
Who should skip
Topical forms are well tolerated; oral tranexamic acid is a prescription drug with clotting cautions and needs a doctor. Results take two to three months, and melasma returns without daily sunscreen.[2]
How to start
Use a 2 to 5% serum once or twice daily on clean skin under moisturizer. It pairs well with niacinamide and is gentle enough for every day.
Melasma responds slowly, so commit to three months, and treat daily broad-spectrum sunscreen as part of the treatment rather than an extra. Common mistakes: stopping after a month, skipping sunscreen on cloudy days, and confusing a topical serum with the oral prescription form, which carries clotting cautions.
Topical use is generally well tolerated. The hydroquinone comparison was small: 20 people with mixed-type melasma in Indonesia used 3% tranexamic acid cream on one side of the face and 4% hydroquinone on the other for 8 weeks.
Both sides improved by week 4, which is encouraging for darker skin tones, but one short trial is Moderate evidence, not proof that it matches hydroquinone over the long term.
What we recommend
We haven't found a product that passes our check yet.
Pairing grid
In tracked products
1 of the 144 products we track list tranexamic acid as a key active; In their ingredient lists it sits at a median position of #8, from #8 in Discoloration Defense to #8 in Discoloration Defense; The actives it most often shares a bottle with: niacinamide (1); Water is the first ingredient in 1 of them; the rest are oil, silicone or solvent-based. Product by product: Discoloration Defense lists it at #8 of 14.
Moisturizer order
Before moisturizer. Full layering steps.
Guides
All tracked products with tranexamic acid
Sources
- Calacattawi R, et al. Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials. J Dermatolog Treat. 2024;35(1):2361106.
- Yasnova N, Sirait SP, Rahmayunita G. The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial. Acta Dermatovenerol Alp Pannonica Adriat. 2024;33(2):83-88.
- Feng X, Su H, Xie J. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: a systematic review and meta-analysis. J Cosmet Dermatol. 2024;23(1):33-43.
- Kornhauser A, Coelho SG, Hearing VJ. Applications of hydroxy acids: classification, mechanisms, and photoactivity. Clin Cosmet Investig Dermatol. 2010;3:135-142.
- Ravikumar B, et al. Efficacy of Alpha and Beta Hydroxy Acid Chemical Peels in Postacne Pigmentation: A Double Blinded, Randomized, Controlled Trial. J Clin Aesthet Dermatol. 2022;15(1):48-52.